주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 16:31
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Celltrion Obtains Recommendation for Marketing Authorization of Xolair Biosimilar ‘CT-P39’ in Europe
Jasmine Choi
2024.03.26 07:53
Celltrion Submits Application for US Approval of ‘CT-P39’
Jasmine Choi
2024.03.12 10:59
Samsung Bioepis Announces Results of Humira Biosimilar Interchangeability Study in US
Jasmine Choi
2024.03.11 12:06
Samsung Bioepis Receives European Recommendation for Stelara Biosimilar Pyzchiva
Choi Mun-hee
2024.02.26 08:32
3 Celltrion Drugs Win Tenders by Public Organizations in Peru
Michael Herh
2024.02.16 13:59
Celltrion Confirms Safety in Phase 1 Trial of Oral Treatment for Autoimmune Diseases
Choi Mun-hee
2024.02.07 11:17
Samsung Bioepis, Celltrion Entangled in Patent Disputes with Original Pharmaceutical Companies
Choi Mun-hee
2024.02.02 14:20
Celltrion Applies for US FDA Approval of Actemra Biosimilar CT-P47
Jasmine Choi
2024.01.30 11:18
Celltrion Launches 80 mg Version of Yuflyma in US
Michael Herh
2024.01.18 12:02
Celltrion Achieves Successive Orders for Autoimmune Disease Similars in Europe
Jasmine Choi
2024.01.12 18:04
Integrated Celltrion to Launch: Global Big Pharma Firm with 12 Trillion Won Revenue
Choi Mun-hee
2023.12.28 09:09
Celltrion Announces Phase 3 Clinical Trial Results for CT-P17, Humira
Jasmine Choi
2023.12.27 15:14
처음
1
2
3
4
5
6
7
8
9
10
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기